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Background: The outcome for opiate dependant patients seeking abstinence is unclear 
in this era of improved access to methadone maintenance.  
Aim: Measure outcome two to three years after inpatient treatment. 
Method: Opiate dependant patients admitted with a goal of abstinence were followed-
up. A structured interview examined drug use and treatment in the preceding month. 
Results: Five patients had died and 109 (76%) of the remaining 144 were followed up. 
Fifty per cent reported recent opiate misuse and 57% were on methadone maintenance. 
Twenty-three per cent were abstinent, i.e. neither using opiates nor on methadone 
maintenance. Abstinence was significantly associated with completion of the six-week 
inpatient treatment program, attendance at outpatient aftercare and negatively 
associated with a family history of substance misuse. 
Conclusions: Abstinence remains an attainable goal. As the principal influence on 
outcome was treatment adherence, inpatient services should seek to enhance rates of 
program completion. Aftercare should be provided to patients. We caution against use 
of pre-treatment patient characteristics as criteria for prioritising access to inpatient 
treatment.  
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Introduction 
 
Large multi-centre studies, such as the National Treatment Outcome Research Study 
(NTORS) in the UK and the Drug Abuse Treatment Outcome Study (DATOS) in 
USA have shown that inpatient treatment reduces mean levels of opiate use (Gossop et 
al, 1999; Hubbard et al, 1997). These studies, which examine heterogeneous 
populations, are limited by they fact that they cannot provide prognostic information 
on achievement of defined goals in the treatment of specific addiction disorders. While 
pre-treatment patient characteristics are poor predictors of treatment outcome, patients 
who spend a longer time in treatment have been shown to have better outcomes 
(Gossop et al, 1999; Chutuape et al, 2001; van de Velde et al, 1998; Ghodse, 2002). 
We hypothesised that a substantial minority of patients would have attained abstinence 
when followed up after inpatient treatment. Secondly, we hypothesised that treatment 
adherence characteristics predict abstinence.  
 
 
Method 
 
Setting 
 
There has been substantial heroin misuse in Dublin since the 1970s. In the early 1990s 
addiction treatment services expanded substantially, moving away from an abstinence 
model and towards a harm reduction model (Farrell et al 1999). Many small treatment 
clinics were opened in communities where opiate misuse was prevalent. General 
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practitioners were recruited and trained to provide treatment for opiate misuse, 
offering both methadone maintenance and methadone reduction (Butler, 2002). Heroin 
misuse accounts for the vast majority of presentations to addiction services in Dublin 
(Smyth et al, 2000).  
 
Cuan Dara opened in 1995, operating as a specialist inpatient drug dependency unit 
(DDU) focusing primarily on detoxification. Prior to admission, all patients were 
expected to have commenced therapeutic work with an addiction counsellor in a 
community based treatment service. Additionally, all patients underwent a psychiatric 
assessment to examine such areas as psychiatric comorbidity and motivation to 
detoxify. The standard treatment program lasted six weeks. This included a ten-day 
methadone detoxification and a benzodiazepine detoxification if indicated. Throughout 
treatment patients were involved in individual therapy and group therapy. This six-
week admission is longer than those DDUs included in NTORS (Gossop et al, 1998). 
Patients were encouraged to access one of two forms of aftercare following discharge. 
They could re-attend their local addiction counsellor or they could access an aftercare 
program in Cuan Dara one evening each week. 
 
 
Patients 
 
Consecutive admissions to the unit from July 1995 to December 1996 were included if 
they met the following criteria: 1/ primary diagnosis was opiate dependence syndrome, 
using ICD-10 criteria and 2/ they were admitted with the goal of ceasing use of all 
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opiates, both illicit and prescribed. Baseline information was obtained from the semi-
structured interview conducted by a psychiatrist on the day of their admission.  
 
 
Follow-up Interview 
 
The core instrument used for data collection during follow-up was the Maudsley 
Addiction Profile (MAP) (Marsden et al, 1998). This instrument yields information on 
the thirty days prior to interview. Eight experienced addiction outreach workers 
conducted interviews. Their expertise ensured that they had the skills and knowledge 
to locate patients both via treatment services and through drug users’ peer networks. 
Follow-up interviews took place between July 1998 and March 1999. It was 
anticipated that the range in time gaps from discharge to follow-up interview would be 
wide. This was a consequence of the facts that patients had been admitted over an 
eighteen months period and were followed up in an opportunistic manner over a ten-
month period. Patients who agreed to participate in the study were paid Ir£10 (12.5 
Euro). Following interview, those who described ongoing drug misuse problems were 
given advice and directed towards appropriate treatment services. 
 
 
Statistical Analysis 
 
The main outcome variable in this study was attainment of abstinence from opiates 
during the month prior to follow-up. Abstinence implied that patients were neither 
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misusing opiates nor being prescribed methadone. The main predictor variables were 
those indicating treatment adherence, i.e. completion of detoxification, completion of 
the six-week inpatient program and attendance at aftercare for at least six months. We 
also explored the possibility that pre-treatment patient characteristics might predict 
abstinence at follow-up. Patients followed up were compared to those whom we failed 
to follow-up in order to outrule any systematic bias in the follow-up group. 
 
Categorical variables were compared using Pearson’s chi squared test or Fishers exact 
test statistic as appropriate. Odds ratios (OR) and their 95% confidence intervals (95% 
CI) were reported to indicate the direction and strength of associations. A multivariate 
analysis was conducted to identify variables that were independently associated with 
opiate abstinence. All variables were eligible for entry into the final regression 
equation. The selection method involved using both the forward and backward 
stepwise selection techniques, using the likelihood-ratio test. The p value for entry was 
set at 0.05 and the p value for removal was 0.10. Variables entered into the final 
regression equation were examined for evidence of interaction. 
 
 
Results 
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Table 1. Baseline characteristics and treatment compliance among 149 opiate dependant 
patients consecutively admitted to a specialist drug dependency unit in Dublin. 
 Characteristic Number (%) 
Total 149 (100) 
     
Socio-demographic and forensic history   
     
 Accommodation   
  Alone or with partner 43 (29) 
  With parents 90 (60) 
  With other relative 7 (5) 
  Hostel or NFA 5 (3) 
     
 Sexual Partner   
  No sexual partner 56 (38) 
  Sexual partner uses opiates 41 (28) 
  Sexual partner not using opiates 49 (34) 
     
 Education   
  Ceased education prior to age 15 years 45 (30) 
  Remained in education until at least age 15  103 (70) 
     
Family history    
     
  History of substance misuse 90 (60) 
   Parental Alcohol abuse 28 (19) 
   Parental opiate use 8 (5) 
   Sibling alcohol abuse 9 (6) 
   Sibling opiate use 58 (39) 
     
Past Addiction Treatment & Psychiatric History   
     
 Number of previous attempted opiate detoxifications   
  None 49 (34) 
  One  41 (28) 
  Two or more 55 (38) 
    
 Past (non-addiction) psychiatric history 43 (29) 
  Inpatient psychiatric treatment 16 (11) 
     
Substance misuse   
     
 Principal opiate of misuse   
  Heroin 131 (89) 
  Methadone 10 (7) 
  Morphine sulphate 2 (1) 
  Combination of opiates 5 (3) 
     
 Quantity of heroin use (per day)   
  Less than 1.5 ‘quarters’ 28 (22) 
  1.5 to 3.0 ‘quarters’ 59 (47) 
  More than 3.0 ‘quarters’ 40 (31) 
     
 Route of use of main drug   
  Chase (smoke) 65 (45) 
  Inject 71 (49) 
  Oral 9 (6) 
     
Compliance with inpatient treatment   
     
 Completion of methadone detoxification   
  Yes 119 (81) 
  No 28 (19) 
     
 Type of discharge   
  Planned 62 (42) 
  Dismissed 8 (5) 
  Discharge against medical advice 74 (51) 
  Transferred elsewhere 2 (1) 
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During the study period, 160 patients were admitted to Cuan Dara. All were opiate 
dependant. Eleven patients were admitted for stabilization of their methadone 
maintenance treatment and were therefore excluded. The remaining 149 sought 
abstinence and were eligible to participate in the study. Males accounted for 67% and 
the median age was 23 years (interquartile range [IQR] 20 to 28). Only 7% reported 
employment and 42% had been in prison. The median duration of opiate use was 4 
years (IQR 2 to 8). Injecting was reported by 79%. Sixty-one per cent were diagnosed 
as benzodiazepine dependent. Additional socio-demographic features, family history, 
previous addiction treatment, psychiatric history and substance misuse characteristics 
are provided in table 1. Eighty-one per cent completed methadone detoxification. 
Overall 56% had an unplanned discharge and their median duration of the admission 
was 14 days (IQR 10 to 23). The median stay of the 44% who had a planned discharge 
was 41 days (IQR 39 to 42).  
 
Five patients were known to have died prior to follow-up. One hundred and nine 
(76%) of the remaining patients were interviewed. We examined the baseline socio-
demographic, drug misuse and treatment adherence characteristics of all patients and 
found no significant differences between those followed up and those not followed up. 
The period from discharge to follow-up ranged from 18 to 42 months, with a median 
of 29 months. Face to face interviews were conducted with all patients apart from five 
who completed telephone interviews. No patients were in residential treatment at 
follow-up. 
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At follow-up 45 (41%) reported heroin use and 20 (18%) reported methadone misuse. 
Overall, 54 (50%) reported misuse of at least one opiate. Sixteen (15%) were using 
heroin daily. Among the 86 patients who completed the methadone detoxification, 46 
(53%) reported no recent opiate misuse. Sixty-two (57%) were on methadone 
maintenance treatment at follow-up.  
 
Table 2. Association between pre-admission characteristics and treatment completion with attainment of the goal 
of abstinence from all opiates ( both illicit and prescribed) at two to three year follow-up among 109 patients 
admitted to a drug dependency unit in Dublin; univariate and multivariate analysis. 
    Univariate analysis Multivariate Analysis* 
 Characteristic 
Numbe
r 
Number 
NOT 
using any 
opiates  
Odd
s 
ratio 95% CI p value AOR 95% CI p value 
Total  109 25       
           
 Imprisonment         
  Never in prison 64 19 1.0      
  In prison 43 6 0.4 0.1 – 1.1 0.06    
           
 Family history         
  No family history of 
substance misuse 43 14 1.0   1.0   
  Family history of substance 
misuse 66 11 0.4 0.2-1.0 0.05 0.3 0.1 – 0.9 0.04 
           
 Number of previous opiate 
detoxifications         
  None 30 9 1.0      
  One or more 76 14 1.9 0.7 – 5.0 0.19    
           
 History of injecting drug use         
  No injecting 26 10 1.0      
  Injected previously 83 15 0.4 0.1 – 0.9 0.03    
           
 Co-dependence on benzodiazepines         
  No 45 14 1.0      
  Yes 63 11 0.5 0.2 – 1.2 0.10    
           
 Completion of methadone 
detoxification         
  Incomplete 21 2 1.0      
  Completed 86 22 3.3 0.70 – 15.2 0.11    
           
 Type of discharge         
  Planned 42 16 4.2 1.1 – 11.1 0.002 4.1 1.4 – 11.9 0.01 
  Unplanned 63 8 1.0   1.0   
           
 Aftercare         
  None or less than six months 83 14 1.0   1.0   
  Six months or more 24 11 4.2 1.6 – 11.2 0.003 7.6 2.3 – 25.3 0.001 
* From the logistic regression equation, the Nakelkerke R2 = 0.31 
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Table 2 indicates the variables associated with the main outcome variable, abstinence 
from all recent opiate use, both illicit and prescribed. Twenty-three per cent reported 
opiate abstinence. Only those characteristics which were at least weakly associated 
with this outcome (odds ratio greater than 2 or less than 0.5) are reported in the table. 
On univariate analysis, abstinence was significantly associated with completion of the 
inpatient treatment programme, attendance at aftercare treatment for at least six 
months following discharge, no previous drug injecting and absence of a family history 
of substance misuse. Abstinence was not associated with other socio-demographic 
characteristics, nor was it associated with past psychiatric history, previous addiction 
treatment, duration of opiate use or quantity of heroin use at baseline. The time 
interval from discharge to follow up was not associated with outcome.  
 
On the multivariate analysis, it emerged that abstinence was significantly associated 
with completion of the inpatient treatment program (OR 4.1, 95% CI 1.4-11.9), 
persistence with aftercare (OR 7.6, 95% CI 2.3-25.3) and an absence of a family 
history of substance misuse (OR 3.3, 95% CI 1.1-9.9).  
 
 
Discussion 
 
Admission characteristics and treatment tenure. 
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The cohort admitted to Cuan Dara was substantially younger and had shorter histories 
of opiate use than their counterparts in other countries (Gossop et al, 1998, Ghodse et 
al 2002; Chutuape et al, 2001; Broers et al, 2000). Over 90% were unemployed but 
they had relatively stable accommodation with over half of the group living with 
parents. Over one third had a sibling who used opiates and almost one fifth reported a 
history of parental alcohol misuse. The rates of completion of the methadone 
detoxification and of the full treatment program are equivalent to those found in other 
inpatient settings (Ghodse et al, 1987; Gossop et al; 1986, Broers et al, 2000; 
Polkinghorne et al, 1996).  
 
 
Follow-up  
 
The follow-up rate achieved in this study is equivalent to that achieved in similar 
studies (Gossop et al, 1999; Hubbard et al 1997). Nevertheless, loss to follow-up is a 
concern as those patients who are difficult to locate may be more likely to be using 
opiates. The absence of any significant difference between the baseline characteristics 
of those followed up compared to those not located suggests selection bias was not 
prominent. 
 
The period from discharge to follow-up varied substantially in this study due to 
methodological issues already discussed. We found no association between duration of 
follow-up and abstinence. NTORS demonstrated that the treatment gains obtained at 
one year remained relatively static at years two and five (Gossop et al, 2003). 
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Although individual patients may move between relapse and abstinence during 
subsequent years, the proportion of patients moving in each direction tend to cancel 
each other out beyond the first year after treatment. 
 
 
Mortality 
 
The five deaths which occurred in this young cohort are consistent with international 
mortality rates of 1 to 2 / 100 person years (Oppenheimer et al, 1994; Gossop et al, 
2002). It should be noted that one of the risks associated with abstinence orientated 
treatments, is the increased risk of accidental overdose following relapse due to the 
reduction in opiate tolerance (Strang et al, 2003). 
 
 
Methadone maintenance treatment 
 
Over half of the cohort was on methadone maintenance treatment at follow-up. This 
indicates that many patients relapsed following discharge and subsequently re-accessed 
treatment. In Switzerland, Broers et al (2000) found that 35% of those admitted for 
inpatient opiate detoxification were on methadone maintenance when followed up after 
six months. Other studies have demonstrated that early relapse is a frequent outcome 
following inpatient treatment (Chutuape et al, 2001). This fact, that opiate dependence 
frequently follows a chronic relapsing course, highlights the need for an accessible and 
comprehensive range of therapeutic interventions for this patient group. 
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Drug misuse outcomes 
 
NTORS demonstrated a significant decline in heroin misuse among patients offered 
residential treatment, from 74% at intake to 49% at one-year follow-up (Gossop et al, 
1999). Both Chutuape et al (2001) and Broers et al (2000) found that about 30% of 
patients reported abstinence from heroin when followed up six months after a brief 
inpatient opiate detoxification. We found that although 89% of the patients were 
admitted with a primary problem of heroin dependence, only 41% reported recent 
heroin misuse at follow-up and only 15% report daily heroin use. Although baseline 
and follow-up data were obtained using different methodologies, our findings support 
the view that inpatient treatment is effective in reducing heroin misuse. Among those 
who completed at least the methadone detoxification phase of treatment we found that 
53% denied any opiate misuse at follow-up. Gossop et al (1989) found an almost 
identical proportion in their six-month follow-up study. 
 
The reduction in misuse of heroin cannot be entirely attributed to inpatient treatment. 
Many patients were on methadone maintenance at follow-up and this will also have 
contributed to the reduced rates of use. While reliance on self-report of substance 
misuse at follow-up may be viewed as a weakness of this study design, similar studies 
have found that self-report correlates highly with results of urine testing (Gossop et al, 
1997; Darke, 1998). 
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Achievement of abstinence 
 
At follow-up, we found that 23% had achieved their initial treatment goal of 
abstinence from opiates without the assistance of methadone maintenance. Most 
studies examining outcome following inpatient treatment report proportions using 
heroin before and after treatment, without making it clear that those who are abstinent 
from heroin at follow-up are not receiving methadone maintenance treatment (Gossop 
et al, 1999; Gossop et al, 1989; Broers et al, 2000; Chutuape et al, 2001). In seeking 
to clarify this important issue, we found that almost one in four were genuinely 
abstinent after an average of two and half years. This finding should be a source of 
optimism to patients, to commissioners of addiction services and to those who deliver 
similar services. It should be noted, however, that abstinence during the month prior to 
follow-up interview does not imply abstinence throughout the follow-up period. 
 
In this era of harm reduction, abstinence has become a more secondary goal of 
treatment services. Dublin has embraced the principles of harm reduction and a well-
developed treatment infrastructure existed at the time of this study (Farrell et al 1999). 
This included relatively easy access to methadone maintenance treatment. Reservations 
have long been expressed that improved access to methadone maintenance might 
reduce the possibility of drug misusers attaining abstinence (Bratter & Pennacchia, 
1978; Gerlach & Schneider, 1991). This study indicates that it remains an attainable 
goal in the current harm reduction environment and confirms our first hypothesis. 
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Abstinent patients were more likely to have completed the inpatient treatment program 
and more likely to have attended aftercare treatment for at least six months. DATOS 
failed to demonstrate that better outcome was predicted by longer stay in short-term 
inpatient treatment such as that delivered in this study (Hubbard et al, 1997). This may 
be due to differences in treatment delivery in USA and substantial differences in the 
patient population as the vast majority of patients in DATOS presented with cocaine 
dependence. There is much other research consistent with our findings that significant 
improvement in outcome is associated with better treatment adherence and with 
transfer to long-term outpatient aftercare following inpatient addiction treatment 
(Gossop et al, 1999; Chutuape et al, 2001; van de Velde et al, 1998; Ghodse, 2002). 
Inpatient treatment is an expensive and limited resource. In order to maximise the 
health gain that such services can deliver we need to identify more effectively those 
patients who are most likely to persist with treatment. There is also a need to improve 
our understanding of the factors within different inpatient and aftercare programs that 
facilitate patient attendance. Finally, there is a need to develop imaginative measures 
which may actively enhance treatment adherence at all stages of the treatment process 
(Horwitz & Horwitz, 1993; Giuffrida & Torgenson, 1997).  
 
The finding that a family history of substance misuse was associated with a significant 
reduction in the likelihood of abstinence was unexpected. There are a number of 
possible explanations for this finding. Environmental explanations seem most plausible. 
Two thirds of those who reported a family history of substance misuse identified a 
sibling who was misusing opiates. Returning home to an environment with an opiate 
using sibling may have made heroin access easier and promoted relapse (Maisto et al, 
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2001). It is also possible that genetic influences contribute to this finding. However, it 
may simply represent a chance finding as a result of a type two statistical error in view 
of the large number of statistical tests conducted in this study. 
 
In common with many other addiction treatment studies, we found that patient pre-
admission characteristics account for a very small proportion of the variance in 
outcome. Consequently, there is minimal evidence to support their use in prioritising 
access to inpatient treatment. 
 
This study suggests that inpatient treatment can be an effective approach for opiate 
dependant patients, particularly in circumstances where the patient completes 
treatment and proceeds to access aftercare. Additionally, evidence from the USA 
indicates that it can also be a cost effective option when compared to outpatient 
treatments (French et al, 2000). Inpatient addiction services must strive to develop 
strategies to improve rates of program completion. Commissioners of addiction 
services should ensure aftercare is available and DDUs should actively facilitate patient 
transfer to such services following discharge. 
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Clinical Implications 
 
 Almost one in four patients report abstinence from opiates, without the 
assistance of methadone maintenance, two to three years after inpatient 
treatment of opiate dependence. 
 Abstinence is associated with completion of the inpatient program and 
attendance at aftercare. Consequently, the health gain from the inpatient 
treatment may be enhanced by taking steps to improve rates of program 
completion and ensuring easy access to aftercare.  
 Pre-treatment socio-demographic and drug misuse characteristics are poor 
predictors of outcome and should not be used as criteria for selection of 
patients into abstinence orientated inpatient treatment. 
 
 
Limitations 
 
 Different methodologies were used to measure substance misuse characteristics 
at baseline and at follow-up. 
 The time-gap from discharge to follow-up varied substantially (from 18 months 
to 42 months). 
 In common with most studies of outcome following addiction treatment, the 
failure to include a control group makes it impossible to determine an effect 
size. 
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